Rastogi, P., Martin, M., Tolaney, S. M., Shao, Z. M., Cortés Castan, J., Fasching, P. A., & Harbeck, N. (2021). Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: Updated efficacy and Ki-67 analysis from the monarchE study.

Rastogi, P., M. Martin, Sara M. Tolaney, Zhi Min Shao, Javier Cortés Castan, Peter A. Fasching, and Nadia Harbeck. Adjuvant Abemaciclib Combined With Endocrine Therapy for High-risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the MonarchE Study. 2021.

Rastogi, P., et al. Adjuvant Abemaciclib Combined With Endocrine Therapy for High-risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the MonarchE Study. 2021.